(Q34022587)

30 July 2017

1 reference

title

Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials (English)

1 reference

relapsing-remitting multiple sclerosis

30 July 2017

0 references

0 references

author name string

M Chofflon

series ordinal

1

1 reference

30 July 2017

publication date

1 July 2000

1 reference

European Journal of Neurology

30 July 2017

published in

1 reference

30 July 2017

volume

7

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

369-380

1 reference

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Recombinant interferon-beta-1a: a review of its therapeutic efficacy in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2000.00057.X

10.1046/J.1468-1331.2000.00057.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference